OBIMF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ondine Biomedical Inc

Watchlist Manager

Watchlist

Price: 0.25 USD Market Closed

Market Cap: $56.7m

O	Ondine Biomedical Inc OTC:OBIMF	CA
	MMA Offshore Ltd ASX:MRM	AU
	Mach7 Technologies Ltd ASX:M7T	AU
	Oncternal Therapeutics Inc NASDAQ:ONCT	US

Profitability Summary

Ondine Biomedical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

61%

Strong 3Y Average Gross Margin

62%

Gross Margin is Increasing

49% > 61%

Negative Operating Margin

-1 133%

Negative 3Y Average Operating Margin

-1 060%

Operating Margin is Increasing

-2 452% > -1 133%

Negative Net Margin

-1 116%

Negative 3Y Average Net Margin

-1 041%

Net Margin is Increasing

-2 326% > -1 116%

Negative Free Cash Flow Margin

-906%

Negative 3Y Average Free Cash Flow Margin

-885%

Free Cash Flow Margin is Increasing

-2 032% > -906%

Negative ROE

-570%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1 202%

Declining ROIC

-605% > -1 411%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.